Endoscopic stent insertion is considered the method of choice for palliation of malignant
bile duct obstruction (MBDO). However, it can cause complications and requires periodic stent
exchanges. While endoscopic stenting is clearly indicated for relief of cholangitis or
refractory pruritus, its role in patients with jaundice alone is less clear. Endoscopic
stenting for this relative indication might be justified, if there is a significant
improvement in quality of life (QOL) of such patients. The aim of the investigators study was
to determine whether endoscopic stenting for MBDO results in improved QOL.